Unexplained visual loss after silicone oil removal associated with thinning of inner retinal layers : 1
Visual acuity changes prior to surgery for idiopathic epiretinal fibrosis : 2
Epidemiology of surgery for rhegmatogenous retinal detachment : 3
Riskfactor analysis and visual outcome after vitrectomy for proliferative diabetic retinopathy : 4
The toxicity of adjuvant drugs used in VR surgery : 6
Macular Epiretinal Brachytherapy in Treated Age Related Macular Degeneration Patients (MERITAGE): interim results : 7
Evaluation of structure and retinal function in longstanding rhegmatogenous detachment after vitreoretinal surgery including retinectomy : 8
Lacrimal gland - non-neoplastic and neoplastic lesions in Denmark : 9
Non-neoplastic lesions of the lachrymal gland : 10
Epithelial tumors of the lacrimal gland : 11
Adenoid cystic carcinoma of the lacrimal gland : 12
Malignant lymphoma of the lacrimal gland : 13
Strabismus surgery for third cranial nerve palsy : 14
Superior oblique palsy : 15
Strabismus in cranial nerve palsies - diagnostic and therapeutic aspects. Sixth nerve palsy : 16
Accommodation measured with optical coherence tomography in patients with Marfan syndrome : 21
Ectopia lentis in children : 22
Verisyse anterior chamber IOLs versus Verisyse retropupillary for aphakia correction: a comparison of outcomes : 23
Late in-the-bag spontaneous intraocular lens dislocation : 24
Late dislocated IOL's : 25
Implications of recent developments in exfoliation glaucoma genetics : 27
Epidemiology of exfoliation syndrome and exfoliation glaucoma : 28
US perspective on clinical features and current medical therapy of exfoliation glaucoma : 29
Filtration/Tube surgery in exfoliation glaucoma : 30
Cataract surgery in exfoliation syndrome and exfoliation glaucoma : 31
Retinal imaging: Current technology and interpretation : 37
Macular disorder in defined genotype in inherent retinal degeneration measured by OCT and mfERG : 38
Functional and structural characterization of macular disease : 39
Enhanced choroidal imaging by optical coherence tomography : 41
Visual and morphological outcome of macular hole surgery : 42
Tube-shunt surgery: Initial experience with the Molteno3 implant : 44
Surgical management options of cataracts for patients nanophthalmos and the ‘small eye phenotype’ : 45
Glaucoma surgery in the myopic eye : 46
Initial experience with canaloplasty in Iceland using iTrack 250 microcatheter with suture tensioning on Schlemm's canal : 47
Aborginal inuit ophthalmology : 54
1911 - An ophthalmologist won the Nobel Price: Allvar Gullstrand, surgeon, mathematician and creative inventor : 55
Nonarteritic anterior ischemic optic neuropathy (NAION) : 56
Drug induced optic neuropathies : 58
One Use-Plus SBK - one-year results : 64
Comparison of FS-LASIK and All-in-One femtosecond laser surgery for myopia : 65
Sub Bowman keratomileusis using the One-Use PLus SBK microkeratome : 66
Anterior segment biometry and refractive status : 67
Mesopic contrast sensitivity: what is normal? : 68
Screening for ROP - experiences from a Swedish population-based study and a national quality register : 62
Long-term follow-up of prematurely-born children : 67
Visual outcome after cataract surgery as reflected by the EUREQUO database : 69
Factors related to the patients' self assessed visual ability after cataract surgery : 70
IOL power calculation: The origin of the refractive error : 71
Surgical complications (capsule complications, afakia, endophthalmatis) : 72
Late complications after cataract surgery : 73
A critical review of: Heimann H et al. VasoProliferative Tumour of the Retina (VPTR). A comparison with material from OUS1 Norway : 74
Tumours of the optic nerve : 75
A critical review of: Abramson DH et al. Direct intraarterial melphalan for intraocular retinoblastoma : 76
The new TNM classification and staging of eye cancer : 77
Uveal melanoma - an update : 78
Design compliance testing of the Icare handheld rebound tonometer : 79
Corneal curvature and thickness in exfoliation syndrome : 80
Glaucoma and dry eye - data from Germany from over 20 000 glaucoma patients : 81
Clinical evaluation of a further developed Applanation Resonance Tonometer : 82
Initial clinical experience with SENSIMED Triggerfish® 24-hr continuous IOP monitoring : 83
Pharmacogenomics and glaucoma treatment : 85
Paediatric cataract surgery in the Ukraine : 86
Persistent fatal vasculature : 87
Treatment after paediatric cataract surgery : 88
Secondary glaucoma after surgery for congenital cataract and application of the ICare Rebound tonometer in healthy infants : 89
Incidence of glaucoma and retinal detachment following paediatric cataract surgery : 90
Visual axis opacification after paediatric cataract surgery : 91
Results of collagen cross-linking for corneal ectasia performed in Oslo University hospital 2007–2009 : 93
Topo-guided PRK and corneal collagen cross-linking : 95
Visual dysfunction following stroke and traumatic brain injury : 97
Improved visual functions through structured visual rehabilitation : 98
Rehabilitation in hemianopia : 99
Emergencies and pitfalls in uveitis : 111
Survival of diabetic patients undergoing vitrectomy : 100
Does retinal microaneurysm score predict progression and regression of diabetic retinopathy? : 101
Foveal neovascularization in a diabetic patient with unusual clinical findings : 102
Effect of cumulative glycemia on risk of retinopathy in type 2 diabetes : 103
Association between retinal vessel diameters and diet : 104
On the ocular refractive components: the Reykjavik Eye Study : 106
Lens transparency property in the human lens, helps predict cataract formation Reykjavík Eye Study : 107
Influence of nuclear cataract and retrodots on visual function : 108
Ocular higher order aberrations due to crystalline lens waterclefts : 109
The WHO cataract classification system helps predict future cataract surgery. Reykjavik Eye Study : 110
When to suspect orbital pathology : 112
Surgical approach to orbital pathology : 113
Decompression in Grave's disease : 114
The post enucleation socket syndrome : 115
Quality of life of eye amputated patients in Denmark : 116
AMD as an ischemic disease : 117
Automatic segmentation of subretinal fluid in patients with choroidal neovascularization using polarization-sensitive optical coherence tomography : 118
Detection of drusen by polarization-sensitive optical coherence tomography : 119
Two-year data from the cornea registry in Oslo : 124
A novel truncating mutation in VLGR1 gene, causing Usher syndrome type II and may also contribute to non-syndromic retinitis pigmentosa : 125
Treatments for all RP-patients? : 127
Phase 2 studies of encapsulated CNTF secreting cell implant (NT-501) in patients with geographic atrophy or retinitis pigmentosa : 128
The size of the problem - glaucoma blindness and impairment : 131
Modern views on target pressure (from EGS guidelines-target pressure should be Dynamic) : 133
Eye amputated patients' perspective on life with an artificial eye : 135
How small is a uveal melanoma when it seeds metastases : 136
Transscleral optical spectroscopy in the diagnosis of choroidal tumours : 137
Evolution of adult-onset asthma with periocular xanthogranulomatosis : 138
Phantom eye syndrome : 139
Occult malignant uveal melanoma after evisceration of blind and/or painful eyes : 140
Retinal oximetry in diabetes and vein occlusions : 141
Retinal oxygen saturation in patients with systemic hypoxemia : 143
Oxygen metabolism in glaucoma : 145
Oxygen metabolism and glaucoma drugs : 146
DSAEK with grafts prepared from the endothelial side using a 500 kHz femto-second laser : 149
Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogs on a 3Dreconstituted corneal epithelium system : 153
12-year Incidence of Exfoliation Syndrome in the Reykjavík Eye Study : 154
Retinal nerve fibre layer thickness and brain volume in acute optic neuritis : 155
Risk factors for prevalence and incidence risk of exfoliation syndrome : 156
Optic disc swelling is related to lesion length in acute optic neuritis : 157
Screening for diabetic retinopathy in private practise Larsen N : 159
Swedish guidelines for retinal photographic screening in type 2 diabetes : 160
Screening intervals for diabetic retinopathy- Which risk indicators are important? : 161
Information technology and diabetic eye screening Pálsson Ó : 162
Individualization of screening intervals. Methodology and practical challenges : 163
Lens yellowing increases the risk of sleep disturbances : 164
First experience with Ellips FX minimal invasive cataract surgery : 165
Comparison of Tecnis 1-piece multifocal versus monofocal intraocular lenses: A prospective clinical multicentre study : 166
Optical rejuvenation of the human lens by photolytic infrared femtosecond laser irradiation - the future treatment of cataract? : 167
Effect of sleep deprivation on the performance of simulated anterior segment surgical skill : 168
Pathologic epithelial and anterior corneal nerve morphology in congenital aniridic keratopathy : 169
In vivo confocal microscopy for assessing inflammatory changes in ocular surface diseases : 170
The corneal endothelium and the Reykjavik Eye Study : 171
Spontaneous corneal perforation in Collodion Baby Syndrome/Lamellar ichthyosis : 172
Rosacea keratitis in childhood - a case report : 173
Incidence and clinical characteristics of congenital ptosis: A population-based study from 1965 to 2004 : 174